TriSalus Life Sciences (TLSI) Financial Statements

78 Followers

TriSalus Life Sciences Financial Overview

TriSalus Life Sciences's market cap is currently $269.61M. The company's EPS TTM is $-1.83; its P/E ratio is -6.74; TriSalus Life Sciences is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Mar 24	Dec 22	Dec 21
Income Statement
Total Revenue	$ 45.15M	$ 29.43M	$ 18.51M	$ 12.40M	$ 8.40M
Gross Profit	$ 38.19M	$ 25.33M	$ 15.91M	$ 10.14M	$ 7.21M
Operating Income	$ -26.95M	$ -36.16M	$ -54.48M	$ -36.44M	$ -24.03M
EBITDA	$ -26.95M	$ -36.16M	$ -58.65M	$ -46.76M	$ -23.57M
Net Income	$ -39.23M	$ -33.23M	$ -59.36M	$ -47.19M	$ -28.84M
Balance Sheet
Cash & Short-Term Investments	$ 20.44M	$ 8.53M	$ 11.78M	$ 9.41M	$ 30.30M
Total Assets	$ 35.33M	$ 23.97M	$ 24.60M	$ 22.00M	$ 37.84M
Total Debt	$ 34.44M	$ 23.63M	$ 1.59M	$ 1.96M	$ 0.00
Net Debt	$ 14.00M	$ 15.10M	$ -10.18M	$ -7.45M	$ -30.30M
Total Liabilities	$ 69.19M	$ 49.87M	$ 51.66M	$ 34.32M	$ 6.93M
Stockholders' Equity	$ -33.86M	$ -25.89M	$ -27.07M	$ -12.32M	$ 30.90M
Cash Flow
Free Cash Flow	$ -18.93M	$ -41.19M	$ -51.17M	$ -33.10M	$ -23.95M
Operating Cash Flow	$ -18.01M	$ -40.84M	$ -50.58M	$ -32.31M	$ -22.70M
Investing Cash Flow	$ -838.00K	$ -345.00K	$ -1.59M	$ -1.79M	$ -2.26M
Financing Cash Flow	$ 30.76M	$ 37.94M	$ 54.63M	$ 13.46M	$ 50.77M

Currency in USD

TriSalus Life Sciences Earnings and Revenue History

Income Statement >

TriSalus Life Sciences Debt to Assets

Balance Sheet >

TriSalus Life Sciences Cash Flow

Cash Flow >

TriSalus Life Sciences Forecast EPS vs Actual EPS

Earnings >